Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Results & Closure of Trading Window

 Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on October 26, 2016, inter alia, to consider the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2016.Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading...
18-10-2016
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results at the 31st Annual General Meeting (AGM) of the Company held on September 14, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report and Proceedings of the Meeting in this regard.
15-09-2016
Bigul

Notice of Annual General Meeting and E-voting published in Newspapers

 Bliss GVS Pharma Ltd has submitted to BSE a copy of Notice of Annual General Meeting and E-voting published in Newspapers.
01-09-2016
Bigul

Outcome of Board Meeting

 Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 27, 2016, at the registered office of the Company at 3.30 p.m., inter alia, has considered and approved the following:- Pursuant to Section 188 of Companies Act, 2013, the Board considered the proposal of taking 9325 sq. ft. area at Hyde Park, Andheri (East) from the Promoters (Related Party Transaction) for the purpose of setting up the Research & Development unit/office.
27-07-2016
Bigul

Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016

 Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 2016
27-07-2016
Bigul

Board Meeting Intimation for Results & Closure of Trading Window

 Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on July 27, 2016, inter alia, to consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2016.Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company...
20-07-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

 Bliss GVS Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
14-07-2016
Bigul

Shareholding for the Period Ended June 30, 2016

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here
13-07-2016
Bigul

Clarification

 With reference to increase in Price and Volume, Bliss GVS Pharma Ltd has submitted to BSE a copy of Clarification is enclosed.
11-07-2016
Bigul

Clarification sought from Bliss GVS Pharma Ltd

 The Exchange has sought clarification from Bliss GVS Pharma Ltd on July 11, 2016, with reference to increase in Price and Volume.The reply is awaited.
11-07-2016
Next Page
Close

Let's Open Free Demat Account